Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin.

Giulia Ferrannini Ulagamadesan Venkatesan Helen Martina ColhounGilles R DagenaisRafael DiazLeanne DyalMark LakshmananLinda MellbinJeffrey L ProbstfieldMatthew Casey RiddleJonathan Edward ShawAlvaro AvezumJan Neil BasileWilliam C CushmanPetr JanskyMátyás KeltaiFernando Tomás Lanas Zanetti Lawrence Alan Leiter Patricio López-JaramilloPrem PaisValdis PīrāgsNana Pogosova Peter Johann RaubenheimerWayne Huey-Herng SheuLars Rydén

Published in: European heart journal (2021)

This analysis suggests that the cardioprotective effect of dulaglutide is unaffected by the baseline use of metformin therapy.

Keyphrases